Health professionals are losing the fight against antibiotic-resistant "superbugs" and few drugs are in development to counter this growing threat, warned infectious diseases experts at a briefing in New York City, USA (April 30). "Immediate national action" is needed to encourage judicious use of antibiotics and better infection-control practices, urged speakers from the Infectious Diseases Society of America (IDSA), the Society for Healthcare Epidemiology of America, and the Society of Infectious Diseases Pharmacists.

"Resistance occurs as a result of antibiotic use, and we\'re using tonnes of antibiotics. And every time you use an antibiotic, either in food production or by prescription, you affect not just the person, but all living organisms and all future living organisms", IDSA representative Martin Blaser (New York University School of Medicine, NY, USA), told *TLID*. "Globally, every time a child comes in with an earache and is given an antibiotic, it puts enormous pressure on the normal respiratory flora. Thus, close to 40% of infections resulting from *Streptococcus pneumoniae* are resistant to penicillin. We\'re already seeing other infections that fail to respond to the first or even second antibiotic prescribed. We\'re running out of options."

Blaser decried the continued use in the USA of subtherapeutic levels of antibiotics to make feed animals gain weight. "If we banned antibiotics from use in the poultry industry (as has happened in Scandinavia and England), the price of poultry would probably go up 1 or 2 cents a pound---a very, very marginal effect. And, if you do the analysis, what it is costing society, in health consequences, is much more. So why aren\'t we banning such things? There are important interests that want to keep antibiotics in food animals---pharmaceutical companies that sell \[the drugs\], and a food industry that wants to produce food at the lowest cost. What we need is political will", Blaser explained.
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Could resistance be contributing to the emergence of severe acute respiratory syndrome (SARS)? "There\'s no obvious connection", Blaser told *TLID*, "but when people get sick and are in the hospital for a week or more, they are at increased risk of acquiring a resistant nosocomial infection. People generally die from SARS after a long hospital stay, and nosocomial infections may well be playing a role".

Robert Weinstein, chair of the US Healthcare Infection Control Practices Advisory Committee, presented strategies for clinicians to prevent antimicrobial resistance in hospitalised patients, including vaccinate, get catheters out quickly, treat infection not contamination or colonisation, know when to say "no" to vancomycin, and prevent transmission of resistant organisms to other patients (see <http://www.cdc.gov/drugresistance/healthcare>).
